Fig. 3From: Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysisSurvival: S-1 vs. close observation. RFS and OS by adjuvant S-1 or OBS (A-B), lymph node stage of N0-1 (C-D), and N2-3 (E-F). Log-rank test, p< 0.05 as statistically significant and shown as *Back to article page